Brainstorm Cell Therapeutics Inc.
BCLI· OTC
BCLIBrainstorm Cell Therapeutics Inc.
Filed Aug 12, 2014 · 10-Q · 43 days after period end · 0001144204-14-048755
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | -$1.98M | -$1.52M | $830.00K | $1.10M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Brainstorm Cell Therapeutics Inc. · CIK 1137883 · Engraved from SEC EDGAR
ended Jun 30, 2014 · filed Aug 12, 2014 · 43 d after period end
